marimastat has been researched along with Orthopedic Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baragi, V; Cody, T; Devalaraja, R; Kaldjian, E; Lesch, C; Qiu, L; Renkiewicz, R; Sun, X; Welgus, H | 1 |
| Peterson, JT | 1 |
| Baillet, M; Forsyth, PA; Fuller, GN; Levin, VA; Maestro, RD; Perry, JR; Phuphanich, S; Yung, WK | 1 |
| Brown, P; Buckels, J; Carmichael, J; Daniel, F; Evans, JD; Imrie, CW; Johnson, CD; Neoptolemos, JP; Stark, A | 1 |
| Baillet, M; Bramhall, SR; Brown, PD; Buckels, JA; Nemunaitis, J; Schulz, J | 1 |
1 review(s) available for marimastat and Orthopedic Disorders
| Article | Year |
|---|---|
Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.
Topics: Cardiomyopathy, Dilated; Collagen; Doxycycline; Drug Design; Enzyme Activation; Enzyme Inhibitors; Extracellular Matrix; Humans; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Musculoskeletal Diseases; Myocardium; Neoplasms; Periodontal Diseases | 2004 |
3 trial(s) available for marimastat and Orthopedic Disorders
| Article | Year |
|---|---|
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Double-Blind Method; Enzyme Inhibitors; Female; Glioblastoma; Gliosarcoma; Humans; Hydroxamic Acids; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Middle Aged; Musculoskeletal Diseases; Quality of Life; Survival Analysis; Treatment Failure | 2006 |
A phase II trial of marimastat in advanced pancreatic cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-19-9 Antigen; Female; Gastrointestinal Diseases; Humans; Hydroxamic Acids; Life Tables; Male; Metalloendopeptidases; Middle Aged; Musculoskeletal Diseases; Neoplasm Proteins; Neoplasm Staging; Pain; Palliative Care; Pancreatic Neoplasms; Pilot Projects; Protease Inhibitors; Quality of Life; Survival Analysis; Treatment Outcome | 2001 |
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Gemcitabine; Humans; Hydroxamic Acids; Life Tables; Male; Matrix Metalloproteinase Inhibitors; Middle Aged; Musculoskeletal Diseases; Neoplasm Proteins; Pancreatic Neoplasms; Protease Inhibitors; Quality of Life; Safety; Survival Analysis | 2002 |
1 other study(ies) available for marimastat and Orthopedic Disorders
| Article | Year |
|---|---|
Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats.
Topics: Animals; Cartilage, Articular; Dose-Response Relationship, Drug; Enzyme Inhibitors; Foot; Gait; Growth Plate; Hindlimb; Hydroxamic Acids; Infusion Pumps, Implantable; Joints; Male; Matrix Metalloproteinase Inhibitors; Musculoskeletal Diseases; Rats; Rats, Inbred Lew; Single-Blind Method; Synovial Membrane | 2003 |